Core Molding Technologies Inc
CMT NYSE Plastics Products, Nec Financials FY2016–FY2025
Last close · Oct 23, 2026
$23.13
4.6%What Core Molding Technologies Inc does
No business description yet.
- Legal name
- CORE MOLDING TECHNOLOGIES INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 10, 2026
- Accession · CIK
- 0001026655-26-000009
0001026655
Revenue and margins
Core Molding Technologies Inc had $274M of revenue in fiscal 2025, down 9.5% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 3.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.9M in fiscal 2025, 0.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Core Molding Technologies Inc returned $3.2M to shareholders in fiscal 2025, 166% of free cash flow. The diluted share count fell 1.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Core Molding Technologies Inc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $6.1M | $4.2M | $24.1M | $41.8M | $38.1M |
| Debt incl. finance leases | $21.3M | $23.0M | $21.5M | $19.7M | $17.6M |
| Net debt / EBITDA | 0.7x | 0.6x | −0.1x | −0.7x | −0.8x |
| Debt / equity | 0.2x | 0.2x | 0.2x | 0.1x | 0.1x |
| Interest coverage | 4.8x | 9.2x | 26.2x | — | 14,218.0x |
| Current ratio | 1.4x | 1.6x | 2.2x | 2.8x | 3.0x |
| Quick ratio | 0.9x | 1.1x | 1.7x | 2.3x | 2.4x |
| Total assets | $187M | $199M | $213M | $210M | $228M |
| Total liabilities | $86.6M | $82.5M | $74.4M | $62.2M | $70.0M |
| Shareholders' equity | $100M | $116M | $139M | $147M | $158M |
| Net debt (− = net cash) | $15.1M | $18.8M | −$2.6M | −$22.1M | −$20.4M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✕ | ✕ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Return on assets rose | — | ✕ | ✕ | ✕ | ✓ | ✕ | ✓ | ✓ | ✕ | ✕ |
| Cash from operations exceeds net income | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Debt fell relative to assets | — | ✓ | ✕ | ✕ | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ |
| Current ratio rose | — | ✕ | ✕ | ✕ | ✓ | ✕ | ✓ | ✓ | ✓ | ✓ |
| Share count didn't rise | — | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✓ |
| Gross margin rose | — | ✕ | ✕ | ✕ | ✓ | ✕ | ✓ | ✓ | ✕ | ✕ |
| Revenue rose relative to assets | — | ✕ | ✓ | ✓ | ✕ | ✓ | ✓ | ✕ | ✕ | ✕ |
| F-score | — / 3 | 4 / 9 | 1 / 9 | 3 / 9 | 7 / 9 | 5 / 9 | 7 / 9 | 7 / 9 | 5 / 9 | 6 / 9 |
| Accruals ratio | −14.0% | −1.1% | 1.0% | −16.8% | −11.6% | −4.5% | −3.5% | −7.0% | −10.3% | −3.7% |
| Altman Z'' | 7.49 | 7.51 | 3.71 | 1.07 | 4.28 | 3.95 | 4.74 | 6.40 | 7.20 | 6.88 |
10 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $175M | $162M | $269M | $284M | $222M | $307M | $377M | $358M | $302M | $274M |
| Gross profit | $27.9M | $24.6M | $27.1M | $21.5M | $34.5M | $41.3M | $52.4M | $64.5M | $53.3M | $47.6M |
| Research and development | $1.0M | $0.8M | $1.0M | $1.2M | $1.2M | $1.3M | $1.6M | $1.7M | $1.9M | $1.4M |
| Operating income | $11.5M | $7.9M | −$3.1M | −$11.5M | $10.4M | $11.1M | $18.0M | $26.5M | $16.7M | $14.2M |
| Interest expense | $0.3M | $0.2M | $2.4M | $4.1M | $5.9M | $2.3M | $2.0M | $1.0M | −$0.2M | $0.0M |
| Pretax income | $11.2M | $7.7M | −$5.4M | −$15.6M | $4.5M | $8.9M | $14.6M | $25.7M | $17.5M | $14.7M |
| Income tax | $3.8M | $2.3M | −$0.7M | −$0.4M | −$3.6M | $4.2M | $2.4M | $5.4M | $4.2M | $3.5M |
| Net income | $7.4M | $5.5M | −$4.8M | −$15.2M | $8.2M | $4.7M | $12.2M | $20.3M | $13.3M | $11.2M |
| Diluted EPS | $0.97 | $0.70 | −$0.62 | −$1.94 | $0.98 | $0.55 | $1.44 | $2.31 | $1.51 | $1.29 |
| Diluted shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $26.1M | $6.9M | −$6.5M | $16.7M | $28.2M | $12.5M | $19.0M | $34.8M | $35.2M | $19.2M |
| Capital expenditure | $2.9M | $4.3M | $5.8M | $7.5M | $3.7M | $11.6M | $16.6M | $9.1M | $11.5M | $17.3M |
| Free cash flow | $23.2M | $2.7M | −$12.3M | $9.2M | $24.5M | $1.0M | $2.4M | $25.7M | $23.6M | $1.9M |
| Depreciation and amortization | $6.3M | $6.2M | $9.4M | $10.4M | $11.7M | $11.6M | $11.9M | $12.9M | $13.4M | $12.3M |
| Stock-based compensation | $1.0M | $1.3M | $1.7M | $1.6M | $1.4M | $1.9M | $2.3M | $2.9M | $2.5M | $1.8M |
| Share buybacks | — | — | $0.3M | $0.1M | $0.0M | $0.1M | $0.0M | $0.0M | $2.9M | $3.2M |
| Dividends paid | $0.0M | $0.8M | $0.8M | $0.0M | $0.0M | — | — | — | — | — |
| Dividends and buybacks | $0.0M | $0.8M | $1.0M | $0.1M | $0.0M | $0.1M | $0.0M | $0.0M | $2.9M | $3.2M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $28.3M | $26.8M | $1.9M | $1.9M | $4.1M | $6.1M | $4.2M | $24.1M | $41.8M | $38.1M |
| Total debt | $12.8M | $6.8M | $41.0M | $50.3M | $25.2M | $21.3M | $23.0M | $21.5M | $19.7M | $17.6M |
| Current assets | $59.9M | $65.0M | $80.3M | $61.2M | $56.5M | $75.1M | $80.7M | $103M | $103M | $103M |
| Current liabilities | $21.3M | $24.6M | $40.2M | $83.8M | $36.0M | $53.1M | $50.8M | $46.2M | $36.7M | $34.2M |
| Inventory | $10.9M | $13.5M | $25.8M | $21.7M | $18.4M | $25.1M | $23.9M | $22.1M | $18.3M | $19.7M |
| Property and equipment, net | $70.6M | $68.6M | $80.7M | $79.2M | $74.1M | $75.9M | $83.3M | $81.2M | $80.8M | $86.9M |
| Goodwill | $2.4M | $2.4M | $21.5M | $17.4M | $17.4M | $17.4M | $17.4M | $17.4M | $17.4M | $17.4M |
| Intangible assets | $0.6M | $0.5M | $15.4M | $13.5M | $11.5M | $9.6M | $7.6M | $6.0M | $4.4M | $3.5M |
| Total assets | $133M | $139M | $201M | $179M | $166M | $187M | $199M | $213M | $210M | $228M |
| Total liabilities | $36.7M | $36.7M | $102M | $94.9M | $71.6M | $86.6M | $82.5M | $74.4M | $62.2M | $70.0M |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $96.8M | $103M | $98.9M | $84.4M | $93.9M | $100M | $116M | $139M | $147M | $158M |
| Margins | ||||||||||
| Gross margin | 16.0% | 15.2% | 10.1% | 7.6% | 15.5% | 13.4% | 13.9% | 18.0% | 17.6% | 17.4% |
| Operating margin | 6.6% | 4.9% | −1.2% | −4.1% | 4.7% | 3.6% | 4.8% | 7.4% | 5.5% | 5.2% |
| EBITDA margin | 10.2% | 8.8% | 2.3% | −0.4% | 9.9% | 7.4% | 7.9% | 11.0% | 10.0% | 9.7% |
| Net margin | 4.2% | 3.4% | −1.8% | −5.4% | 3.7% | 1.5% | 3.2% | 5.7% | 4.4% | 4.1% |
| FCF margin | 13.3% | 1.6% | −4.6% | 3.3% | 11.0% | 0.3% | 0.6% | 7.2% | 7.8% | 0.7% |
| Returns | ||||||||||
| Return on capital | 9.4% | 6.7% | −1.8% | −6.9% | 9.0% | 6.2% | 11.2% | 15.4% | 10.1% | 7.9% |
| Return on capital employed | 10.3% | 7.0% | −1.9% | −12.1% | 8.0% | 8.3% | 12.2% | 15.9% | 9.7% | 7.3% |
| Return on equity | 7.7% | 5.5% | −4.7% | −16.6% | 9.2% | 4.8% | 11.3% | 15.9% | 9.3% | 7.3% |
| Return on assets | 5.6% | 4.0% | −2.8% | −8.0% | 4.7% | 2.7% | 6.3% | 9.9% | 6.3% | 5.1% |
| Return on tangible equity | 7.9% | 5.5% | −7.7% | −28.4% | 12.6% | 6.4% | 13.4% | 17.6% | 10.6% | 8.2% |
| Growth | ||||||||||
| Revenue growth | — | −7.6% | 66.7% | 5.5% | −21.8% | 38.3% | 22.7% | −5.2% | −15.5% | −9.5% |
| Net income growth | — | −26.3% | −187.6% | — | — | −42.8% | 161.3% | 66.5% | −34.6% | −15.8% |
| EPS growth | — | −27.8% | −188.6% | — | — | −43.9% | 161.8% | 60.4% | −34.6% | −14.6% |
| FCF growth | — | −88.6% | −564.7% | — | 164.9% | −96.0% | 145.0% | 975.3% | −8.2% | −91.9% |
| Share count change | — | 1.1% | 0.0% | 1.0% | 1.4% | 1.5% | 3.8% | 4.8% | 0.2% | −1.0% |
| Financial health | ||||||||||
| Net debt / EBITDA | −0.9x | −1.4x | 6.2x | — | 1.0x | 0.7x | 0.6x | −0.1x | −0.7x | −0.8x |
| Debt / equity | 0.1x | 0.1x | 0.4x | 0.6x | 0.3x | 0.2x | 0.2x | 0.2x | 0.1x | 0.1x |
| Interest coverage | 38.7x | 32.4x | −1.3x | −2.8x | 1.8x | 4.8x | 9.2x | 26.2x | — | 14,218.0x |
| Current ratio | 2.8x | 2.6x | 2.0x | 0.7x | 1.6x | 1.4x | 1.6x | 2.2x | 2.8x | 3.0x |
| Quick ratio | 2.3x | 2.1x | 1.4x | 0.5x | 1.1x | 0.9x | 1.1x | 1.7x | 2.3x | 2.4x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.6% | 2.6% | 2.2% | 2.6% | 1.7% | 3.8% | 4.4% | 2.5% | 3.8% | 6.3% |
| Stock comp / revenue | 0.6% | 0.8% | 0.6% | 0.6% | 0.6% | 0.6% | 0.6% | 0.8% | 0.8% | 0.7% |
| Payouts / FCF | 0.0% | 29.6% | — | 1.1% | 0.1% | 9.8% | 0.0% | 0.0% | 12.4% | 165.6% |
| Quality scores | ||||||||||
| Piotroski F-score | — | 4.0 | 1.0 | 3.0 | 7.0 | 5.0 | 7.0 | 7.0 | 5.0 | 6.0 |
| Altman Z'' | 7.5 | 7.5 | 3.7 | 1.1 | 4.3 | 4.0 | 4.7 | 6.4 | 7.2 | 6.9 |
| Accruals ratio | −14.0% | −1.1% | 1.0% | −16.8% | −11.6% | −4.5% | −3.5% | −7.0% | −10.3% | −3.7% |
Source: SEC EDGAR XBRL filings (CIK 0001026655). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
